Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Marijuana derivative helps tackle seizure frequency in epilepsy patients

Marijuana derivative helps tackle seizure frequency in epilepsy patients

24th December 2015

Children and young adults with severe, highly treatment-resistant epilepsy could benefit from using a medical marijuana derivative.

Tests at New York University Langone Medical Center revealed that Cannabidiol (CBD) can be effective in reducing the number of seizures experienced by young people with the condition.

The study, which was published in the December issue of Lancet Neurology, also revealed that CBD is both well-tolerated and safe for the majority of those who underwent this course of treatment.

Dr Orrin Devinsky, professor of neurology, neurosurgery and psychiatry and director of the Comprehensive Epilepsy Center at NYU Langone, described the findings as encouraging.

However, he insisted that additional research needs to be carried out before patients can benefit more widely.

"Before we raise hopes for families who regularly deal with the devastation of treatment-resistant epilepsy, more research, including further studies through our ongoing randomised controlled trial, are needed to definitively recommend CBD as a treatment to patients with uncontrolled seizures," Dr Devinsky commented.ADNFCR-8000103-ID-801808900-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.